-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TxzRNwixgr3tBUrHyy4nnSB6+rRZSoAusqauK686ds9rj+HhB8G3Zxmx+H42Y8R2 08mLfnZTBLyMtCQuWu55uA== 0001140361-06-005753.txt : 20060411 0001140361-06-005753.hdr.sgml : 20060411 20060411195134 ACCESSION NUMBER: 0001140361-06-005753 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060411 FILED AS OF DATE: 20060411 DATE AS OF CHANGE: 20060411 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TARGACEPT INC CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 200 EAST FIRST STREET STREET 2: SUITE 300 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 BUSINESS PHONE: 3364802100 MAIL ADDRESS: STREET 1: 200 EAST FIRST STREET STREET 2: SUITE 300 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dunbar Geoffrey C CENTRAL INDEX KEY: 0001296025 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 06754597 BUSINESS ADDRESS: BUSINESS PHONE: 3384802100 MAIL ADDRESS: STREET 1: C/O TARGACEPT, INC. STREET 2: 200 EAST FIRST STREET, SUITE 300 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 3 1 doc1.xml FORM 3 X0202 3 2006-04-11 0 0001124105 TARGACEPT INC TRGT 0001296025 Dunbar Geoffrey C C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300 WINSTON-SALEM NC 27101 0 1 0 0 VP - Clin. Dev. & Reg. Affairs Common Stock 22602 D Employee Stock Option (right to buy) 2011-05-31 Common Stock 7625 D Employee Stock Option (right to buy) 5.1 2002-02-15 2012-02-14 Common Stock 4896 D Employee Stock Option (right to buy) 2013-01-30 Common Stock 15999 D Employee Stock Option (right to buy) 2013-10-30 Common Stock 59276 D Employee Stock Option (right to buy) 5.625 2004-01-26 2014-01-25 Common Stock 3950 D Employee Stock Option (right to buy) 1.75 2015-03-28 Common Stock 54000 D This option vests 25% on June 30, 2002 and then in 12 equal quarterly installments thereafter, or, if earlier, upon completion of the issuer's initial public offering. The portion of this option that was not yet exercisable as of March 31, 2005 was repriced on April 7, 2005 to $1.75 per share. Following the repricing, of the 7,625 shares of common stock underlying this option, the exercise price for 6,354 shares is $5.10 per share and the exercise price for 1,271 shares is $1.75 per share. This option vests 25% on January 31, 2003, and then in equal installments at the end of the following 16 calendar quarters, or, if earlier, upon completion of the issuer's initial public offering. The portion of this option that was not yet exercisable as of March 31, 2005 was repriced on April 7, 2005 to $1.75 per share. Following the repricing, of the 15,999 shares of common stock underlying this option, the exercise price for 10,749 shares is $5.10 per share and the exercise price for 5,250 shares is $1.75 per share. This option vests 20% on October 31, 2003, and then in equal installments at the end of the following 16 calendar quarters. The portion of this option that was not yet exercisable as of March 31, 2005 was repriced on April 7, 2005 to $1.75 per share. Following the repricing, of the 59,276 shares of common stock underlying this option, the exercise price for 29,638 shares is $5.10 per share and the exercise price for 29,638 shares is $1.75 per share. This option vests 20% on March 29, 2005, and then in equal installments at the end of the following 16 calendar quarters. /s/ Geoffrey C. Dunbar 2006-04-11 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document
 
Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, DC 20549

Re: Targacept, Inc.

Gentlemen:

Pursuant to General Instruction 7 to Form 3 (Initial Statement of Beneficial Ownership), Form 4 (Statement of Changes in Beneficial Ownership) and Form 5 (Annual Statement of Changes in Beneficial Ownership) promulgated by the Securities and Exchange Commission pursuant to Section 16 of the Securities Exchange Act of 1934, the undersigned director, officer and/or shareholder of Targacept, Inc. (the "Company") hereby authorizes and designates Peter A. Zorn, Mauri Hodges, and Alan A. Musso, and each of them, to execute and file with the Commission on his behalf any and all statements on Form 3, Form 4 or Form 5 relating to his beneficial ownership of securities of the Company as required by Section 16(a) of the Securities Exchange Act of 1934 and the rules of the Commission promulgated thereunder. This authorization and designation shall be effective for so long as the undersigned remains subject to the provisions of Section 16 of the Securities Exchange Act of 1934.

Effective as of April 11, 2006.


 
/s/ Geoffrey C. Dunbar
  
 
Geoffrey C. Dunbar
  
 
 


 -----END PRIVACY-ENHANCED MESSAGE-----